NCT01647984View on ClinicalTrials.gov

Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias

PHASE4CompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

December 31, 2014

Conditions
Ventricular and Atrial Extrasytoles
Interventions
DIETARY_SUPPLEMENT

Ritmonutra

Ritmonutra ® contains: 720 mg of Fish Oil with Omega-3, including 480 mg of EPA and 40 mg of DHA, Hawthorn (extract from Crataegus mongyna) 300 mg equivalent to 5.4 mg of vitexin, 4 mg of Astaxanthin and 36 mg of Vitamin E

DIETARY_SUPPLEMENT

placebo

Trial Locations (1)

80131

Ambulatorio Ipertensione e Unità Coronarica Federico II University, Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT01647984 - Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias | Biotech Hunter | Biotech Hunter